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Our understanding of genomic regulation was revolutionized by the discovery that the
genome is pervasively transcribed, giving rise to thousands of mostly uncharacterized
non-coding ribonucleic acids (ncRNAs). Long, ncRNAs (lncRNAs) have thus emerged as
a novel class of functional RNAs that impinge on gene regulation by a broad spectrum of
mechanisms such as the recruitment of epigenetic modiﬁer proteins, control of mRNA
decay and DNA sequestration of transcription factors. We review those lncRNAs that
are implicated in differentiation and homeostasis of metabolic tissues and present novel
concepts on how lncRNAs might act on energy and glucose homeostasis. Finally, the
control of circadian rhythm by lncRNAs is an emerging principles of lncRNA-mediated gene
regulation.
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INTRODUCTION
THE NON-CODING GENOME
The canonical view of mammalian genomes revolves around
the notion that the roughly 20,000 proteins within mammalian
genomes are interspersed by somewhat conserved, yet function-
ally redundant non-coding regions with only limited regulatory
potential. Regulatory properties of these “non-coding” regions
were only attributed to cis-regulatory elements such as promoters
or cis/trans-enhancer regions. This paradigm was fundamentally
called into question by results obtained fromwhole-transcriptome
sequencing efforts [e.g., by theENCODEconsortium(Birney et al.,
2007; Thomas et al., 2007)] over the last decade that have revealed
the pervasive transcription of mammalian genomes (Carninci
et al., 2005; Birney et al., 2007; Derrien et al., 2012). Although
the magnitude of pervasiveness remains under debate (van Bakel
et al., 2010; Clark et al., 2011), recent meta-analyses of human
ribonucleic acid-sequencing (RNA-Seq) datasets have conﬁrmed
that >80% of genomic sequences are rediscovered within RNA
transcripts, often in a temporally and spatially speciﬁc manner
(Hangauer et al., 2013). One logical consequence of pervasive
transcription is the abundance of non-coding RNAs (ncRNAs)
within mammalian genomes, a phenomenon which holds true for
most eukaryotic species ranging from yeast (David et al., 2006), to
Drosophila (Stolc et al., 2004), plants (Li et al., 2006) and humans
(Hangauer et al., 2013). Given the predicted high number of ncR-
NAs within mammalian genomes, which probably surpasses that
of coding genes, it is not surprising that a large conceptual void
remains about the multifaceted role of ncRNAs in regulation of
gene expression. Researchers have historically divided ncRNAs
into small ncRNAs (sRNAs <200 nt length) such as microR-
NAs (miRNAs) and small nucleolar RNAs (snoRNAs) in contrast
to so-termed long ncRNAs (lncRNAs; >200 nt length). Until
today, the identiﬁcation of biological processes, which are reg-
ulated by miRNAs as well as the elucidation of mRNA targets,
which are posttranscriptionally regulated by disease-associated
miRNAs remains an important focus of research (Bartel, 2009;
Carthew and Sontheimer, 2009). It was demonstrated that the
spectrum of biological processes, which are regulated by miR-
NAs, ranges from the development of organs, the homeostatic
regulation of cellular metabolism to aging and neurodegenerative
disorders. Although miRNAs are central to the understanding of
the non-coding genome, the regulation of energy homeostasis and
metabolism by miRNAs has been meticulously reviewed elsewhere
(Lynn, 2009; Rottiers and Naar, 2012; Kim and Kyung Lee, 2013)
and goes beyond the scope of this review. In contrast to miR-
NAs, the role of lncRNAs in control of metabolism and energy
homeostasis remains rather elusive. Thus, we here review the
known roles for lncRNAs, which probably constitute the numer-
ical majority of ncRNAs encoded within mammalian genomes,
during differentiation, homeostasis and metabolic regulation of
tissues (Figure 1).
LONG NON-CODING RNAs
Those lncRNAs that were initially discovered in the late eight-
ies had distinct, at that time considered exotic functions such
as X chromosome inactivation in females by the lncRNA XIST
(Penny et al., 1996). Another historical example was the imprinted
lncRNA H19, which is involved in repression of Igf2 (Pachnis et al.,
1988). After the discovery of pervasive genomic transcription it
became clear that lncRNAs do not represent an exotic observa-
tion, but rather a prominent feature of the genome (Birney et al.,
2007). Although the number of lncRNAs is still debated, recent
meta-analyses posit the human genome to give rise to >60,000
lncRNA, albeit the majority is probably expressed at low levels
(Derrien et al., 2012; Hangauer et al., 2013; for current lncRNA
numbers consult NONCODE Version 4, www.noncode.org).
Interestingly, lncRNAs on one hand exhibit many similarities
with protein-coding transcripts: As true for mRNAs, lncRNAs
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FIGURE 1 | Schematic illustration of selected lncRNAs involved in the
control of organ differentiation and development (e.g., CDR1as, Bvht,
and linc-MD1), tissue homeostasis (e.g., Lnc-RAPs and HI-LNCs) and
control of circadian rhythm (e.g., asPer2 ). For detailed description of
lncRNA mode-of-action please refer to the main text.
are transcribed by RNA-polymerase (Pol) II (Guttman et al.,
2009), spliced at canonical splicing sites (Chew et al., 2013), are
partly polyadenylated (Cabili et al., 2011) and even associate with
polysomes (Guttman et al., 2013). Further, lncRNAs harbor the
same chromatin marks of H3K4 and H3K36 trimethylation as
found in active promoters and transcribed regions of protein-
coding transcripts, respectively, a phenomenon which aided in
the identiﬁcation of novel lncRNAs (Mikkelsen et al., 2007). It
is noteworthy that the notion of distinct mRNA-like trimethy-
lation marks on actively transcribed lncRNAs is incompatible
with the criticism brought forward according to which lncR-
NAs are merely generated by unspeciﬁc Pol II activity which
leads to low-level transcription of non-coding sequences (“tran-
scriptional noise”; Derrien et al., 2012). On the other hand,
certain features set lncRNAs apart from protein-coding genes:
Generally, lncRNAs are expressed at lower levels, are less evolu-
tionarily conserved and less frequently associate with ribosomes
than protein-coding transcripts (Hangauer et al., 2013). Further,
lncRNA are shorter than coding genes and are composed of
a unique gene structure of usually 1–2 exons. Of note, some
lncRNAs do give rise to small peptides and may act as both,
coding and non-coding, transcript (reviewed here Dinger et al.,
2008).
PRINCIPLES OF lncRNA-MEDIATED GENE REGULATION
Currently, intensive research efforts are underway to better under-
stand the molecular basis of gene regulation by lncRNAs. To date,
four major paradigms have emerged on how lncRNA impinge on
gene regulation:
(EPIGENETIC) REGULATION OF GENE TRANSCRIPTION
LncRNAs are able to bring gene-regulatory DNA-binding pro-
teins and DNA sequences into close proximity and thus constitute
an ideal docking platform for recruiting epigenetic modiﬁers to
distinct genomic loci in cis- or trans. Indeed, early insights into
lncRNA-based gene regulation have revealed the recruitment of
the inhibitory polycomb repressive complex (PRC) 2 and the acti-
vating Trithrorax/MLL chromatin modiﬁers to speciﬁc genomic
loci by the lncRNAs HOTAIR (Rinn et al., 2007) and HOTTIP
(Wang et al., 2011), respectively. PRC2 and MLL then mark dis-
tinct lysine residues within histones via trimethylation, leading
to inhibition or activation of gene transcription. In a similar
fashion, the lncRNA ANRIL silences the INK4a tumor suppres-
sor allele by H3K27 trimethylation via recruiting the Polycomb
chromatin modiﬁer CBX7 (Yap et al., 2010). The percentage of
lncRNAs implicated in (epigenetic) gene regulation was system-
atically quantiﬁed by interrogating the PRC2 interactome using
chromatin-state maps. This revealed the abundant interaction of
Polycomb repressor proteins with up to 20% of expressed lncR-
NAs (Khalil et al., 2009). Thus, one prominent role of lncRNAs
relates to writing and erasing chromatin marks, thereby control-
ling the epigenetic state of lncRNA-bound genomic loci (Spitale
et al., 2011). In a systematic attempt to interrogate the function of
3019 human lncRNAs, Orom et al. (2010) revealed that a signiﬁ-
cant portion of the lncRNome possesses cis-regulatory enhancer
properties (hitherto termed enhancer-like RNAs, eRNAs), which
control the expression of neighboring protein-coding genes. Ele-
gant follow-up studies using chromosome conformation capture
(3C) technology revealed that the co-activator complex Media-
tor is involved in tethering eRNAs to their gene targets. Hence,
lncRNAs regulate the three-dimensional (3D) structure of chro-
mosomes via Mediator-dependent chromosome looping (Lai
et al., 2013), thereby bridging large intra- and interchromosomal
distances in order to activate distal promoters (reviewed in Orom
and Shiekhattar, 2013). This study nicely complemented reports
about the lncRNA-mediated regulation of HOXA genes, in which
chromosomal looping brings the eRNA HOTTIP in proximity to
its target genes, marks the chromatin by H3K4 trimethylation
and thus activates gene transcription (Wang et al., 2011). Taken
together, the translation of the information content that lies within
higher-order (3D) structures of chromosomes into (epigenetic)
modiﬁcations of chromatin and regulation of gene transcription
seems to be an emerging principle of lncRNA function.
PROCESSING/DEGRADATION OF mRNA
Every step of RNA metabolism is subjected to ﬁne-tuned and
complex regulation (reviewed in Moore, 2005). LncRNAs have
recently been involved in the control of RNA stability, the process-
ing of (pre)-mRNAs and the regulation of mRNA decay. Natural
antisense transcripts (NATs) are lncRNAs which are characterized
by their location antisense to other coding or non-coding tran-
scripts (Faghihi and Wahlestedt, 2009). The upregulation of NATs
often causes downregulation of protein-coding transcripts on the
opposite strand by the formation of RNA duplexes and triggering
of cellular RNAi, although recently the NAT-mediated upregu-
lation of protein-coding transcripts on the opposite strand were
reported (Carrieri et al., 2012). The repressive effect of NATs onto
the opposite strand not only holds true for duplexes consisting
of (i) a protein-coding mRNA and a non-coding lncRNA NAT,
but also for (ii) duplexes between a lncRNA NAT and another
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lncRNAs as demonstrated for lncRNAs which base-pair with and
target the PTEN pseudogene PTENpg1 (Johnsson et al., 2013).
The lncRNA-mediated regulation of (pre)-mRNA processing was
demonstrated for the nuclear retained lncRNA MALAT1, which
modulates alternative splicing via assembly of serine/arginine
splicing factors within subnuclear compartments called nuclear
speckles (Tripathi et al., 2010). Finally, the timely degradation
of mRNAs by a process called Staufen-mediated decay (SMD)
involves lncRNA-recipient sequences in the 3′UTR of SMD tar-
get genes. Here, intermolecular base-pairing between lncRNAs
and sequences within the 3′UTR of Staufen (Stau) target genes
triggers a cellular SMD response and the ensuing degradation
of the transcript (Gong and Maquat, 2011; Wang et al., 2013).
The in vivo signiﬁcance of lncRNA-mediated SMD decay was
underscored by the observation that epidermal differentiation
critically depends on lncRNA-elicited mRNA decay. Here, a
lncRNA called TINCR is recruited to speciﬁc sequences called
“TINCR box” within TINCR target genes and elicits the decay
of TINCR-bound transcripts by SMD (Kretz et al., 2013; Kretz,
2013).
POSTTRANSCRIPTIONAL GENE REGULATION
MiRNAs recognize their gene targets by binding to 6–8 nt
sequences called “seeds” located in the 3′UTR region of protein-
coding RNAs (Bartel, 2009). It was demonstrated that recognition,
binding and degradation/translational inactivation of miRNA tar-
gets is not necessarily conﬁned to protein-coding transcripts.
A so-called “competing endogenous RNA (ceRNA) hypothesis”
was brought forward according to which protein-coding RNAs,
miRNAs, and lncRNAs transcripts form large-scale regulatory
networks which impinge on the expression of other transcripts
independently of protein translation via competing for a lim-
ited pool of miRNAs (Salmena et al., 2011). Here, transcripts,
so-called ceRNAs regulate the expression of other transcripts
based on the similarity of their 3′UTR miRNA response ele-
ments (MRE) proﬁle. According to this notion, two transcripts
with a strong degree of common MREs can crosstalk to each
other by competing for a given pool of miRNAs. Upregulation
of one ceRNA increasingly “sponges” a limited pool of miRNAs
and relieves the miRNA-mediated repressive tone on ceRNA-
linked transcripts. The experimental conﬁrmation of a ceRNA-like
interdependency of protein-coding transcripts was ﬁrst demon-
strated for the tumor suppressor gene PTEN (Karreth et al.,
2011; Tay et al., 2011), which “crosstalks” to hitherto unknown
tumor suppressors. PTEN loss-of-function during cancerogen-
esis is also controlled by the genomic loss of its (non-coding)
pseudogene PTENP1 which acts as a ceRNA (Poliseno et al.,
2010). An additional layer of posttranscriptional regulation by
lncRNAs accordingly lies within the speciﬁc pattern of MREs
within lncRNAs which allow it to inﬂuence the expression of cod-
ing and non-coding transcripts in a ceRNA-like fashion. This
is exempliﬁed by the upregulation of a non-coding antisense
homologue of the beta-secretase BACE1 (BACE1-AS) that acts
as BACE1 ceRNA and concomitantly increases Bace1 mRNA
stability and leads to augmented deposition of Aβ-plaques in
Alzheimer’s disease (AD; Faghihi et al., 2008, 2010). Finally, a
novel, intriguing class of functional lncRNAs, which is encoded
in eukaryotic genomes, is constituted by circular RNAs (cir-
cRNAs). CircRNAs are expressed at high levels, can act as
ceRNAs and effectively sponge miRNAs as shown for the neu-
roendocrine miRNA miR-7 (Hansen et al., 2013; Memczak et al.,
2013).
REGULATION OF PROTEIN ACTIVITY
Ribonucleic acid possesses the unique biochemical property to
recognize and bind most biomolecules including proteins with
unprecedented afﬁnity (Stoltenburg et al., 2007). Thus, lncRNAs
can speciﬁcally bind proteins and elegant studies have attributed
novel roles for lncRNAs in the control of tissue homeostasis via
direct binding and modiﬁcation of protein activity. For exam-
ple, a lncRNA termed Evi2 was shown to form stable complexes
with members of the Dlx/Dll family of transcription factors,
which are crucial regulators of developmental timing in verte-
brates, and thereby regulate their transcriptional output (Feng
et al., 2006). Further, two lncRNAs termed PRNCR1 and PCGEM1
that are upregulated in aggressive prostate cancer, synergistically
and coordinately bind the carboxyterminal part of the andro-
gen receptor (AR) and are required for AR-dependent gene
transcription. In androgen-refractory prostate cancer, PRNCR1
and PCGEM1 are robustly expressed and are implicated in the
ligand-independent activation of AR signaling [AR “resistant”
prostate cancer (Yang et al., 2013)]. Another emerging paradigm
of lncRNA-mediated regulation of protein activity is the seques-
tration of transcription factors as exempliﬁed by the lncRNA
Gas5, which is induced under conditions of nutrient depriva-
tion and cellular stress. Gas5 acts as glucocorticoid receptor (GR)
decoy by competing with GR-responsive elements (GREs) in gene
promoters for binding to the DNA-binding domain of the GR
(Kino et al., 2010). Increased levels of Gas5 thus interfere with
GR binding to the DNA and effectively inhibit transactivation
of GR-dependent gene promoters. Another example is nuclear
factor kappa b (NFkB) signaling, which translates extracellu-
lar, proinﬂammatory cues [e.g., by tumor necrosis factor alpha
(TNF-α) receptor activation] into changes in gene expression.
NFkB activation induces the transcription of a speciﬁc subset
of lncRNAs, apart from the induction of classical inﬂammatory
protein-coding genes. Among this subset of TNF-regulated lncR-
NAs, a lncRNA termed Lethe is recruited to the NFkB effector
subunit RelA in an inducible fashion and inhibits RelA from DNA-
binding and target gene activation (Rapicavoli et al., 2013). Finally,
the hypoxia-regulated lncRNA linc-p21 was shown to physically
interact with hypoxia-inducible factor (HIF) 1alpha transcription
factors. This HIF1a-linc-p21 circuit controls the hypoxia-evoked
increases of the glycolytic “Warburg effect” in tumor cells (Yang
et al., 2014).
LncRNAs IN CONTROL OF METABOLISM
The regulation of metabolism and glucose homeostasis is orches-
trated and ﬁne-tuned by a complex interplay of tissues/organs.
Currently, we are faced with an unprecedented rise of obesity
in the civilized world and the concurrent increase in obesity-
associated diseases such as insulin resistance and type 2 dia-
betes mellitus (T2D). Key to the understanding of whole-body
metabolism are the pleiotropic effects of the anabolic master
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regulator insulin which simultaneously controls peripheral as well
as central-nervous system-related aspects of metabolism (Kahn
et al., 2006). Resistance toward the effects of insulin consti-
tutes a key step in the development of metabolic disease. The
exciting observation that insulin and insulin-like growth fac-
tor (IGF) 1 signaling also triggers distinct changes in lncRNA
expression [e.g., of the lncRNA CRNDE (Ellis et al., 2013)]
points to the fact that lncRNAs may also be implicated in the
metabolic effects of insulin and the development of insulin
resistance. Thus, a strong interest lies within the identiﬁcation
of lncRNA-mediated mechanisms governing energy and glu-
cose homeostasis at the cell-intrinsic, organ and whole-body
level.
TISSUE-SPECIFIC REGULATION OF METABOLISM BY
lncRNAs
MAINTENANCE OF PANCREATIC BETA CELL IDENTITY
The main function of pancreatic islets lies within the synthesis,
storage and secretion of insulin and glucagon, two hormonal
regulators of glucose homeostasis. The possible control of islet
development and function by lncRNAs was ﬁrst demonstrated
in studies which reported that the lncRNA H19 is involved
in the intergenerational transmission of diabetes mellitus [ges-
tational diabetes mellitus (GDM)] and the GDM-associated
impairments of islet infrastructure and function (Ding et al.,
2012). Global lncRNA screening approaches conducted by Moran
et al. (2012) systematically interrogated the lncRNA transcrip-
tome in human pancreatic beta cells. Here, the dynamic, strand
and tissue-speciﬁc regulation of >1,000 lncRNA was reported
using integrated transcriptional and chromosomal maps. Uti-
lizing RNA-Seq data of 16 non-pancreatic tissues, the afore-
mentioned gene set of pancreatic lncRNAs was shown to be
signiﬁcantly more speciﬁc for islet cells (40–55% for intergenic
and antisense lncRNAs, respectively) than protein-coding genes
(9.4%). Furthermore, the upregulation of islet-speciﬁc lncRNAs
during progenitor commitment, glucose-stimulated upregula-
tion and the striking dysregulation of islet-speciﬁc lncRNAs in
patients with T2D pointed to a pathophysiological role of lncR-
NAs in the homeostasis of pancreatic tissues. The fact that a
signiﬁcant percentage of mouse and human lncRNA orthologs
display similar cell- and stage-speciﬁc expression patterns sug-
gests that evolutionarily conserved properties of lncRNAs extend
beyond their primary sequence. This study was corroborated by
a publication from the McManus laboratory, which presented
a new catalog of the human beta cell (non-coding) lncRNA
transcriptome in which >1,000 lncRNA were expressed in an
islet-speciﬁc fashion involving islet-speciﬁc splicing events and
promoter utilization (Ku et al., 2012). However, the elucida-
tion of the molecular mechanisms underlying lncRNA-mediated
regulation of beta cell differentiation and function still await
discovery.
REGULATION OF ADIPOGENESIS AND ADIPOSE TISSUE PLASTICITY
Thebodyharbors twoprincipal types of adipose tissueswhichpos-
sess key functions in regulating the equilibrium between nutrient
deposition and energy expenditure: Whereas white adipose tissue
(WAT) serves as storage organ for excess nutrients, brown adipose
tissue (BAT) dissipates the proton gradient across mitochondrial
membranes to generate heat via the BAT-intrinsic uncoupling pro-
tein 1 (UCP1; Bartelt and Heeren, 2012). The accumulation of
excess lipids that leads to low-grade inﬂammation inWAThas been
linked to the development of insulin resistance in obese patients
(Saltiel and Kahn, 2001; Gregor and Hotamisligil, 2011; Glass and
Olefsky, 2012). Also, impaired BAT thermogenesis can contribute
to the development of insulin resistance and obesity (Connolly
et al., 1982; Feldmann et al., 2009). The fact that lncRNAs are
implicated in the differentiation of adipose tissues (adipogenesis)
is exempliﬁed by the lncRNA SRA, which is required for full trans-
activation of the proadipogenic transcription factor Peroxisome
proliferator-associated receptor gamma (Pparg). Concomitantly,
RNAi-mediated SRA loss-of-function interfered with in vitro
differentiation of 3T3-L1 preadipocytes (Xu et al., 2010). In a
seminal study by Sun et al. (2013), the systematic implication of
lncRNAs during adipogenesis was addressed. Using global tran-
scriptome proﬁling of undifferentiated and mature adipocytes
from the WAT and BAT lineages, the signiﬁcant and speciﬁc
regulation of 175 lncRNAs during adipogenesis was reported
(Sun et al., 2013) of which a signiﬁcant portion were enriched
within adipose tissues. Finally, subsets of newly identiﬁed lncR-
NAs termed lncRAPs (lncRNAs Regulated in AdiPogenesis) were
depleted in vitro using siRNAs. Distinct lncRAPs, which were
speciﬁcally upregulated during adipogenesis and were induced
by the proadipogenic transcription factors Cebpa and Pparg,
were required for timely and complete maturation of adipocyte
progenitor cells. These studies provide ﬁrst evidence for a cru-
cial role of lncRNAs in the control of adipogenesis and fat cell
metabolism.
DIFFERENTIATION OF SKELETAL MUSCLE AND CARDIOMYOCYTES
The differentiation of skeletal muscle cells (myogenesis) is regu-
lated by a complex, yet well understood, evolutionarily conserved
circuitry of protein-coding genes which control the timely growth,
morphogenesis, and terminal maturation of muscle progenitors
(myoblasts; Buckingham and Vincent, 2009). Here, the implica-
tion of noncoding RNAs was ﬁrst shown via the contribution of
myogenic miRNAs (myomiRs like miR-1 and miR-133) during
myoblast commitment (Chen et al., 2006; Liu et al., 2008). Gong
and Maquat (2011) reported that in human cells the degrada-
tion of distinct, nascent coding transcripts by Staufen-mediated
decay (SMD) was regulated by lncRNAs. Here, the intermolecular
base-pairing between Alu elements located within the 3′UTR of
an SMD target and an Alu site localized within a class of lncR-
NAs called 1/2sbsRNAs (1/2-STAU1-binding site RNAs) triggered
SMD (Gong and Maquat, 2011). This process was interestingly
conserved in rodents that lack canonical Alu repeats. Here, the
mouse homologue of 1/2sbsRNA was shown to be implicated in
terminal differentiation of myoblast cells (Wang et al., 2013), indi-
cating a function of lncRNAs in myogenesis. Another lncRNA
termed linc-MD1 is also critical for myogenesis. Here, increased
levels of linc-MD1 trigger the muscle differentiation program
by acting as a natural decoy for myomiRs miR-133 and miR-
135 (Cesana et al., 2011). MiR-133 and -135 in turn repress the
expression of two pro-myogenic transcription factors, MAML1
and MEF2C. Recent reports also revealed that linc-MD1 takes part
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in a molecular feedforward circuit involving the promyogenic pro-
tein HuR (Legnini et al., 2014). Collectively, linc-MD1 promotes
terminal differentiation of myoblasts via acting as ceRNA for myo-
genic transcriptional regulators by sequestering anti-myogenic
miRNAs. Interestingly, this complex ceRNA-based interplay of
classical mRNAs, lncRNAs, and miRNAs was dysregulated in
patients suffering from Duchenne muscular dystrophy (DMD),
a condition of reduced terminal differentiation of myoblasts.
Reinstating DMD-associated downregulation of linc-MD1 expres-
sion via lentiviral delivery led to improved maturation of DMD
myoblasts. In a study published by Klattenhoff et al. (2013),
the heart-intrinsic lncRNA Braveheart (Bvht) was demonstrated
to be required for differentiation of mesodermal progenitors
toward mature cardiomyocytes via interaction with PRC2 epi-
genetic modiﬁers. This report for the ﬁrst time implicated a
tissue-speciﬁc lncRNA in maintaining cell fate during mammalian
organogenesis.
REGULATION OF NEUROGENESIS BY lncRNAs
The discovery that peripherally secreted hormones such as insulin
and leptin control energy homeostasis and glucose metabolism
via CNS-acting neurocircuits expanded our understanding on
how the body ingests, stores and dissipates energy (Belgardt and
Bruning, 2010). In an approach to identify lncRNAs, which are
implicated in brain development and neurogenesis, Aprea et al.
(2013) utilized transgenic in vivo approaches to isolate neural
stem cells, partially committed neuronal precursor cells as well
as terminally differentiated neurons and quantiﬁed the expression
of lncRNAs. Several lncRNAs were identiﬁed that were involved
in neurogenesis, neuroblast commitment and neuron survival as
shown for the neuroregulatory lncRNA Miat. Thus, maintenance
of the neuron stem cell pool and terminal differentiation of neuron
progenitors are also under lncRNA-mediated control. This will
hopefully entail studies in the future speciﬁcally addressing the
regulation of deﬁned neuronal circuits, which regulate peripheral
metabolic by lncRNAs.
REGULATION OF CIRCADIAN RHYTHM BY lncRNAs
The mammalian clock plays a fundamental role in the regulation
of energy and glucose homeostasis. Dysregulation of the circadian
rhythm underlies several metabolic pathologies like the develop-
ment of insulin resistance and the metabolic syndrome (Marcheva
et al., 2010; Hatori et al., 2013). In addition to the central clock
located in the suprachiasmatic nucleus (SCN) of the pineal gland
in the CNS, subordinate, tissue-speciﬁc clocks exist which are
also key for the regulation of diurnal aspects of lipid metabolism,
oscillations in core body temperature and timely insulin secre-
tion from pancreatic beta cells (Cretenet et al., 2010; Marcheva
et al., 2010; Gerhart-Hines et al., 2013). Interestingly, as found
for plants (Hazen et al., 2009), lncRNAs are involved in the reg-
ulation of vertebrate circadian systems. A study published by
Coon et al. showed that 112 lncRNAs are differentially expressed
between day/night within the pineal gland of rats (Coon et al.,
2012). An in-depth investigation of eight highly rhythmic lncRNA
revealed the pivotal role of neuronal projections from the SCN
as well as external zeitgebers like light exposure onto periodicity
and amplitude of circadian lncRNAs. In addition, a report from
Vollmers et al. (2012) observed that rhythmic expression of ncR-
NAs likeNATs, lncRNAs andmiRNAs leads to rhythmic chromatin
modiﬁcations in the liver. Noteworthy, the circadian oscillator
component Per2 itself is controlled by an antisense lncRNA termed
asPer2. Reports about the brain-derived regulation of circadian
metabolism remain scarce yet the pathogenesis of Prader–Willi
syndrome (PWS), a CNS-controlled genetic disorder circadian
rhythm with an associated dysregulation of metabolism and the
development of obesity, was shown to be inﬂuenced by a PWS-
associated lncRNAcalled 116G.After splicing, a lncRNAconsisting
of the remnants of 116G (termed 116HG) bound to the tran-
scriptional activator RBBP5 and ensures a physiological circadian
rhythm in the brain. Mice deﬁcient for 116HG exhibit metabolic
disorders due to the dysregulation of diurnally expressed circa-
dian genes like Clock, Cry1, and Per2 in the CNS (Powell et al.,
2013).
EMERGING CONCEPT: INTERCELLULAR COMMUNICATION BY
EXOSOMAL lncRNAs?
Exosomes are small vesicles generated by budding of the plasma
membrane and constitute a speciﬁc vehicle for intercellular com-
munication. Upon release from donor cells, exosomal surface
motifs serve as “address codes” for binding and endocytosis on
acceptor cells. Speciﬁc exosomal shuttling RNAs (esRNAs) such
as miRNAs can be packaged into exosomes and released after
binding to recipient cells, thus constituting a novel and intrigu-
ing way for ncRNAs to regulate systemic aspects of metabolism
(Ramachandran and Palanisamy, 2012). Similarly, the intercellu-
lar transport of high-density lipoproteins (HDL)-bound miRNAs
that are released by distinct donor cells inﬂuence the miRNA pro-
ﬁle of acceptor cells and concomitantly alter the gene expression
in HDL-recipient target tissues (Vickers et al., 2011). Of note, deep
sequencing of human exosomes revealed that lncRNAs are local-
ized within micro-vesicles and may emerge as novel means of
cellular communication (Huang et al., 2013). Although experi-
mental proof of concept is still lacking, the endocrine transfer
of exosomal lncRNA might represent a novel facette relevant for
lncRNA-mediated control of metabolism.
THERAPEUTIC OPPORTUNITIES OF lncRNA INHIBITION
A high economic interest lies in the development of sequence-
speciﬁc compounds for the inhibition of disease-associated ncR-
NAs. Short, chemically modiﬁed ribonucleic acid compounds
like locked nucleic acids (LNAs) efﬁciently silence the expres-
sion of ncRNAs such as miRNAs and are generally well tolerated
in vivo (Krutzfeldt et al., 2005; Esau et al., 2006; Elmen et al.,
2008). These anti-RNA compounds were initially tested in mice
(Krutzfeldt et al., 2005) and adopted to the non-human pri-
mate situation (Elmen et al., 2008) with unprecedented speed.
This approach will hopefully be extended to disease-associated
lncRNA in the near future. Most in vivo studies to date concen-
trated on disease-associated miRNAs, that were critically involved
in the development of insulin resistance and the deterioration
of metabolic health (Jordan et al., 2011; Trajkovski et al., 2011;
Zhou et al., 2012; Kornfeld et al., 2013). In contrast, most insights
concerning themetabolic functions of lncRNAswere inferred from
in vitro studies. The rising numbers of lncRNA knockout models
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[exempliﬁed by a recent report on 18 lncRNA loss-of-function
mouse models (Sauvageau et al., 2013)] showcase that in order to
convincingly assess, whether lncRNAs are implicated in the in vivo
control of metabolism, further animal models for lncRNA loss-
and gain-of-function are needed. This is of timely importance
as systemic antisense oligonucleotide (ASO)-mediated inhibition
of disease-associated lncRNAs (even in difﬁcult to target organs
like skeletal muscle) effectively improves degenerative diseases
like myotonic dystrophy type 1 (DM1) in mice (Wheeler et al.,
2012).
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